Long-term complications of radiotherapy;Les complications a long terme de la radiotherapie

Presse Medicale

Volumn 26, Issue 23, 1997, Pages 1107-1110

  Cosset, J M ^a   Henry Amar, M ^b  

^a INSTITUT CURIE   (France)

^b CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; HEART INFARCTION; HODGKIN DISEASE; HUMAN; LINEAR ACCELERATOR; LONG TERM CARE; METASTASIS; PERICARDITIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REVIEW; SOLID TUMOR; IATROGENIC DISEASE; MORTALITY; RISK FACTOR; TIME;

HODGKIN DISEASE; HUMANS; IATROGENIC DISEASE; RISK FACTORS; TIME FACTORS;

EID: 0030874368     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. nd Ed. Cambridge, 1980.
2. Henry-Amar M, Joly F. Late complications after Hodgkin's disease. Ann Oncol 1996 ; 7:S115-16.
3. Gustavsson A, Eskilsson J, Landberg T et al. Long-term effects on pulmonary function of mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol 1992 ; 3:455-61.
4. Hassink EAM, Souren TS, Boersma J. Pulmonary morbidity 10-18 years after irradiation for Hodgkin's disease. Eur J Cancer 1993 ; 29A:343-7.
5. Horning SJ, Adhikari A, Riszk N, Hoppe RT, Olshen RA. Effect of treatment for Hodgkin's disease on pulmonary function:results of a prospective study. J Clin Oncol 1994 ; 12:297-305.
6. Cosset JM, Henry-Amar M, Girinsky T, Malaise E, Dupouy N, Dutreix J. Late toxicity of radiotherapy in Hodgkin's disease:the role of fraction size. Acta Oncol 1988 ; 27:123-9.
7. Cosset JM, Henry-Amar M, Meerwaldt JH et al. Long-term toxicity of early stages Hodgkin's disease therapy: the EORTC experience. Ann Oncol 1991 ; 2:77-82.
8. Dubray B, Henry-Amar M, Meerwaldt JH et al. Radiation-induced damage after thoracic irradiation for Hodgkin's disease:the role of fractionation. Radiother Oncol 1995 ; 36:211-17.
9. Hirsch A, Vander N, Straus DJ et al. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease. J Clin Oncol 1996 ; 14:1297-305.
10. Cosset JM, Henry-Amar M, Pellae-Cosset B et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy at the Institut Gustave Roussy. Int J Radiat Oncol Biol Phys 1991 ; 21:447-9.
11. Gerling B, Gottdiener J, Borer JS. Cardiovascular complications of the treatment of Hodgkin's disease. In: Hodgkin's Disease: the consequences of survival, Lacher MJ, Redman JR eds: Lea and Febiger, Philadelphia, London 1990 ; 267-75.
12. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993 ; 270:1949-55.
13. Pierga JY, Maunoury C, Valette H et al. Follow-up Thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1992 ; 25:871-976.
14. Cosset JM, Henry-Amar M, Burgers JMV et al. Late injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials:Emphasis on the role of exploratory laparotomy and fractionation. Radiother Oncol 1988 ; 13:61-8.
15. Coia LR, Hanks GE. Complications from large field intermediate dose infradiaphragmatic radiation:an analysis of the pattern of care outcome studies for Hodgkin's diseases and seminoma. Int J Radiat Oncol Biol Phys 1988 ; 15:29-35.
16. Cosset JM. Maladie de Hodgkin ; vers une désescalade thérapeutique ? Rev Prat Méd Gén 1993 ; 25-30.
17. Hancock SL, Cox RS, Mc Dougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991 ; 325:599.
18. Sebag-Montefiore DJ, Maher EJ, Young J, Vaughan Hudson G, Hanks C. Variation in mantle technique: implications for establishing priorities for quality assurance in clinical trials. Radiother Oncol 1992 ; 23:144-9.
19. Blayney DW, Longo DL, Young RC et al. Decreasing risk of leukaemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 1987 ; 316:710-14.
20. Andrieu JM, Ifrah N, Payen C et al. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. J Clin Oncol 1990 ; 8:1148-54.
21. Van Leeuwen FE, Klokman WJ, Hagenbeek A et al. Second cancer risk following Hodgkin's disease: A 20 year follow-up study. J Clin Oncol 1994 ; 12:312-25.
22. Henry-Amar M. Second cancer after the treatment for Hodgkin's disease:A report from the International Database on Hodgkin's disease. Ann Oncol 1992 ; 3:S117-28.
23. Henry-Amar M. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease. NCl Monogr 1988 ; 6:65-72.
24. Van Leeuwen FE, Klokman WJ, Stovall M et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 1995 ; 87:1530.
25. Kaldor JM, Day NE, Bell J et al. Lung cancer following Hodgkin's disease: A case-control study. Int J Cancer 1992 ; 52:677-81.
26. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993 ; 85:25.
27. Bhatia S, Robison LL, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996 ; 334:745.
28. Tucker MA, Jones PH, Boice JDJ et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991 ; 51:2885.
29. Dietrich PY, Bellefqih S, Henry-Amar M et al. Linitis plastica after Hodgkin's disease. Lancet 1993 ; 342:57-8.
30. Hancock SL, Hoppe RT, Horning SJ et al. Intercurrent death after Hodgkin's disease therapy in radiotherapy and adjuvant MOPP trials. Ann Intern Med 1988 ; 109:183-9.
31. Henry-Amar M, Somers R. Long term survival in early stages Hodgkin's disease: The EORTC experience, H.-A. M. In: Treatment strategy in Hodgkin's disease, Somers R Meerwaldt JH, Carde P eds. Colloque INSERM, Paris 1990; 151-66.